AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54

Authors: Ben Sedrine, W Devogelaer, JP Kaufman, JM Goemaere, S Depresseux, G Zegels, B Deroisy, R Reginster, JY
Citation: W. Ben Sedrine et al., Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium, BONE, 29(4), 2001, pp. 374-380

Authors: Zegels, B Eastell, R Russell, RGG Ethgen, D Roumagnac, I Collette, J Reginster, JY
Citation: B. Zegels et al., Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis, BONE, 28(1), 2001, pp. 108-112

Authors: Brandi, ML Gennari, L Cerinic, MM Becherini, L Falchetti, A Masi, L Gennari, C Reginster, JY
Citation: Ml. Brandi et al., Genetic markers of osteoarticular disorders: facts and hopes, ARTHRITIS R, 3(5), 2001, pp. 270-280

Authors: Emery, P Reginster, JY Appelboom, T Breedveld, FC Edelmann, E Kekow, J Malaise, M Mola, EM Montecucco, C Sanda, M Sany, J Scott, DL Serni, U Seydoux, G
Citation: P. Emery et al., WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis, RHEUMATOLOG, 40(6), 2001, pp. 699-702

Authors: Ben Sedrine, W Radican, L Reginster, JY
Citation: W. Ben Sedrine et al., On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center, RHEUMATOLOG, 40(1), 2001, pp. 7-14

Authors: Vignon, E Garnero, P Delmas, P Avouac, B Bettica, P Boers, M Ehrich, E MacKillop, N Rovati, L Serni, U Spector, T Reginster, JY
Citation: E. Vignon et al., Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers, OSTEO CART, 9(4), 2001, pp. 289-293

Authors: Henrotin, Y de Leval, X Mathy-Hartet, M Mouithys-Mickalad, A Deby-Dupont, G Dogne, JM Delarge, J Reginster, JY
Citation: Y. Henrotin et al., In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators, INFLAMM RES, 50(8), 2001, pp. 391-399

Authors: Valat, JP Accardo, S Reginster, JY Wouters, M Hettich, M Lleu, PL
Citation: Jp. Valat et al., A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine, INFLAMM RES, 50, 2001, pp. S30-S34

Authors: Reginster, JY Zegels, B Lejeune, E Micheletti, MC Taquet, AN Albert, A
Citation: Jy. Reginster et al., Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion, GYNECOL END, 15(1), 2001, pp. 56-62

Authors: Reginster, JY Rovati, LC Setnikar, I
Citation: Jy. Reginster et al., Correct regimen of fluoride and calcium reduces the risk of vertebral fractures in postmenopausal osteoporosis, OSTEOPOR IN, 12(9), 2001, pp. 800-800

Authors: Koh, LKH Ben Sedrine, W Torralba, TP Kung, A Fujiwara, S Chan, SP Huang, QR Rajatanavin, R Tsai, KS Park, HM Reginster, JY
Citation: Lkh. Koh et al., A simple tool to identify Asian women at increased risk of osteoporosis, OSTEOPOR IN, 12(8), 2001, pp. 699-705

Authors: Reginster, JY Christiansen, C Roux, C Fechtenbaum, J Rouillon, A Tou, KP
Citation: Jy. Reginster et al., Intermittent cyclic tiludronate in the treatment of osteoporosis, OSTEOPOR IN, 12(3), 2001, pp. 169-177

Authors: Tellier, V De Maeseneer, J De Prins, L Ben Sedrine, W Gosset, C Reginster, JY
Citation: V. Tellier et al., Intensive and prolonged health promotion strategy may increase awareness of osteoporosis among postmenopausal women, OSTEOPOR IN, 12(2), 2001, pp. 131-135

Authors: Henrotin, Y Labasse, A Zheng, SX Galais, P Tsouderos, Y Crielaard, JM Reginster, JY
Citation: Y. Henrotin et al., Strontium ranelate increases cartilage matrix formation, J BONE MIN, 16(2), 2001, pp. 299-308

Authors: Paul, I Bilge, A Bolly, F Boland, J Reginster, JY
Citation: I. Paul et al., Pilot study for the registration of acute myocardial infarction in the Liege area (Belgium), REV EPIDEM, 49(5), 2001, pp. 423-429

Authors: Reginster, JY
Citation: Jy. Reginster, Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women, CLIN EXP RH, 19(2), 2001, pp. 121-122

Authors: Massart, F Reginster, JY Brandi, ML
Citation: F. Massart et al., Genetics of menopause-associated diseases, MATURITAS, 40(2), 2001, pp. 103-116

Authors: Appelboom, T Schuermans, J Verbruggen, G Henrotin, Y Reginster, JY
Citation: T. Appelboom et al., Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in kneeosteoarthritis - A double blind, prospective, placebo-controlled study, SC J RHEUM, 30(4), 2001, pp. 242-247

Authors: Reginster, JY Henrotin, Y Christiansen, C Gamwell-Henriksen, E Bruyere, O Collette, J Christgau, S
Citation: Jy. Reginster et al., Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I, CALCIF TIS, 69(3), 2001, pp. 130-137

Authors: Reginster, JY Rovati, LC Henrotin, Y Giacovelli, G Gosset, C
Citation: Jy. Reginster et al., Glucosamine sulphate and osteoarthritis - Reply, LANCET, 357(9268), 2001, pp. 1618-1618

Authors: Reginster, JY Deroisy, R Rovati, LC Lee, RL Lejeune, E Bruyere, O Giacovelli, G Henrotin, Y Dacre, JE Gossett, C
Citation: Jy. Reginster et al., Long-term effects of glucosamine sulphate on osteoarthritis progression: arandomised, placebo-controlled clinical trial, LANCET, 357(9252), 2001, pp. 251-256

Authors: Alexandersen, P Toussaint, A Christiansen, C Devogelaer, JP Roux, C Fechtenbaum, J Gennari, C Reginster, JY
Citation: P. Alexandersen et al., Ipriflavone in the treatment of postmenopausal osteoporosis - A randomizedcontrolled trial, J AM MED A, 285(11), 2001, pp. 1482-1488

Authors: Reginster, JY Gillet, P Gosset, C
Citation: Jy. Reginster et al., Secular increase in the incidence of hip fractures in Belgium between 1984and 1996: need for a concerted public health strategy, B WHO, 79(10), 2001, pp. 942-946

Authors: McClung, MR Geusens, P Miller, PD Zippel, H Bensen, WG Roux, C Adami, S Fogelman, I Diamond, T Eastell, R Meunier, PJ Reginster, JY Wasnich, RD Greenwald, M Kaufman, J Chestnut, CH
Citation: Mr. Mcclung et al., Effect of risedronate on the risk of hip fracture in elderly women, N ENG J MED, 344(5), 2001, pp. 333-340

Authors: Neer, RM Arnaud, CD Zanchetta, JR Prince, R Gaich, GA Reginster, JY Hodsman, AB Eriksen, EF Ish-Shalom, S Genant, HK Wang, OH Mitlak, BH
Citation: Rm. Neer et al., Effect of parathyroid hormone (1-34) on fractures and bone mineral densityin postmenopausal women with osteoporosis., N ENG J MED, 344(19), 2001, pp. 1434-1441
Risultati: 1-25 | 26-50 | 51-54